Author:
Li Weiming, ,Wang Danyu,Guo Jingming,Yuan Guolin,Yang Zhuangzhi,Gale Robert Peter,You Yong,Chen Zhichao,Chen Shiming,Wan Chucheng,Zhu Xiaojian,Chang Wei,Sheng Lingshuang,Cheng Hui,Zhang Youshan,Li Qing,Qin Jun,Meng Li,Jiang Qian
Funder
DH | National Institute for Health Research
National Natural Science Foundation of China
Publisher
Springer Science and Business Media LLC
Subject
Oncology,Cancer Research,Hematology
Reference19 articles.
1. Liang W, Guan W, Chen R, Wang W, Li J, Xu K, et al. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol. 2020;21:335–7.
2. Zhang L, Zhu F, Xie L, Wang C, Wang J, Chen R, et al. Clinical characteristics of COVID-19-infected cancer patients: A retrospective case study in three hospitals within Wuhan, China. Ann Oncol. 2020:S0923-7534(20)36383-3.
3. Xia Y, Jin R, Zhao J, Li W, Shen H. Risk of COVID-19 for patients with cancer. Lancet Oncol. 2020;21:e180.
4. Wang H, Zhang L. Risk of COVID-19 for patients with cancer. Lancet Oncol. 2020;21:e181.
5. Yu J, Ouyang W, Chua MLK, Xie C. SARS-CoV-2 transmission in patients with cancer at a Tertiary Care Hospital in Wuhan, China. JAMA Oncol. 2020. https://doi.org/10.1001/jamaoncol.2020.0980.
Cited by
75 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献